Selected Publications
- Potter, DM, Butterfield LH, Divito SJ, Sander CA, Kirkwood JM. Pitfalls in Retrospective Analyses of Biomarkers: a Case Study with Metastatic Melanoma Patients. J. Immunol. Meth. 2012 Feb 28;376(1-2):108-12.
- Okada, H., Kalinski, P., Ueda, R., Hoji, A., Kohanbash, G., Donegan, T., Mintz, A., Engh, J., Bartlett, D., Brown, C., Zeh, H., Holtzman, M., Reinhart, T., Whiteside, T.L., Butterfield, L.H., Hamilton, R., Potter, D., Pollack, I., Salazar, A. and Lieberman, F. Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with alpha-type-1-polarized dendritic cells and poly ICLC in patients with recurrent malignant glioma. J Clin Oncol. 2011 Jan 20;29(3):330-6.
- Schaefer C, Butterfield LH, Lee S, Kim G, Visus C, Albers A, Kirkwood JM, Whiteside TL. Function but not phenotype of melanoma peptide-specific CD8+ T cells correlate with survival in a multi-epitope peptide vaccine trial (ECOG 1696). Int. J. Cancer 2011 Oct 24.
- Bedognetti D, Balwit JM, Wang E, Disis ML, Britten CM, Delogu LG, Tomei S, Fox BA, Gajewski TF, Marincola FM, Butterfield LH. SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery. J. Trans. Med., 9:155, 2011.
- Butterfield LH, Potter DM, Kirkwood JM. Multiplex Serum Biomarker Assessments: Technical and Biostatistical Issues. J. Trans. Med., 9:173, 2011.
- Butterfield LH, Palucka AK, Britten CM, Dhodapkar MV, Hakansson L, Janetzki S, Kawakami Y, Kleen T-O, Lee PP, Maccalli C, Maecker HT, Maino VC, Maio M, Malyguine A, Masucci G, Pawelec G, Potter DM, Rivoltini L, Salazar LG, Schendel DJ, Slingluff CL, Jr., Song W, Stroncek DF, Tahara H, Thurin M, Trinchieri G, van Der Burg SH, Whiteside TL, Wigginton JM, Marincola F, Khleif S, Fox BA and Disis ML. Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers. Clin Cancer Res. 2011 May 15;17(10):3064-76.
